user Sign In

QYResearch Account

Manage your Account and Access Personalized Content.

Sign in

Create Account with us

Manage your Account and Access Personalized Content.

Sign Up
       
  
×

United States Injectable Drug Delivery Devices Market Report 2018

Published Date: 2018-02-07   |   Pages: 108   |   Tables: 124   | Report Id: 207987   | Hits: 18 |   Injectables



In this report, the United States Injectable Drug Delivery Devices market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Injectable Drug Delivery Devices in these regions, from 2013 to 2025 (forecast).

United States Injectable Drug Delivery Devices market competition by top manufacturers/players, with Injectable Drug Delivery Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Alkermes

Genentech

Bend Research

QLT

Endocyte

BIND Biosciences

UCB Group (UCB)

Presage Bioscience

Polymer Factory

MicroCHIPS

Pearl Therapeutics

Piedmont Pharmaceuticals

Zogenix

Liquidia Technologies

Impax Laboratories

Boehringer Ingelheim

Crossject Medical Technology

Apogee Technology

Pulmatrix

Medicago

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Conventional Drug Delivery Devices

Novel Drug Delivery Devices

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospitals

Clinics

Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Licenses Type

Only one user can access the report
Multiple users can access the report

Why QYR

 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehensive analysis
 Excellent after sales support
 Owns large database

Need Help ?

QYR Clients

More Clients...